Serum concentration of heart-type fatty acid-binding protein in children and adolescents with congenital heart disease

Circulation Journal

Volumn 75, Issue 8, 2011, Pages 1992-1997

  Hayabuchi, Yasunobu ^a   Inoue, Miki ^a   Watanabe, Noriko ^a   Sakata, Miho ^a   Ohnishi, Tatsuya ^a   Kagami, Shoji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Chronic heart failure; Congenital heart disease; Hypoxia; Pediatrics

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; CREATINE; CREATINE KINASE MB; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; LOOP DIURETIC AGENT; OXYGEN; SPIRONOLACTONE; UNCLASSIFIED DRUG;

ADULT; AGE; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOPULMONARY CONNECTION; BLOOD LEVEL; CAVOPULMONARY CONNECTION; CHILD; CONGENITAL HEART DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FONTAN PROCEDURE; GREAT VESSELS TRANSPOSITION; HEART ATRIUM SEPTUM DEFECT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HEART VENTRICLE SEPTUM DEFECT; HOME OXYGEN THERAPY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATENT DUCTUS ARTERIOSUS; PATIENT CARE; PATIENT MONITORING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; PROSPECTIVE STUDY; PULMONARY VALVE ATRESIA; REGRESSION ANALYSIS; SCHOOL CHILD; TRICUSPID VALVE ATRESIA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CREATINE KINASE, MB FORM; CREATININE; CROSS-SECTIONAL STUDIES; FATTY ACID-BINDING PROTEINS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MALE; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; STROKE VOLUME;

EID: 79960801256     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-1256     Document Type: Article

References (28)

1. Sugimoto M, Manabe H, Nakau K, Furuya A, Okushima K, Fujiyasu H, et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children: Correlation with the heart failure score and comparison with B-type natriuretic peptide. Circ J 2010; 74: 998-1005.
2. Picchio FM, Formigari R, Balducci A. Pediatric heart failure. Minerva Cardioangiol 2008; 56: 311-319.
3. Odland HH, Thaulow EM. Heart failure therapy in children. Expert Rev Cardiovasc Ther 2006; 4: 33-40.
4. Shah M, Hasselblad V, Tasissa G, Christenson RH, Binanay C, O'Connor CM, et al. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol 2007; 100: 1427-1433.
5. Kawahara C, Tsutamoto T, Nishiyama K, Yamaji M, Sakai H, Fujii M, et al. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J 2011; 75: 656-661.
6. Fukushima Y, Nakanishi M, Nonogi H, Goto Y, Iwai N. Assessment of plasma miRNAs in congestive heart failure. Circ J 2011; 75: 336-340.
7. Hamaguchi S, Tsuchihashi-Makaya M, Kinugawa S, Goto D, Yokota T, Goto K, et al. Body mass index is an independent predictor of long-term outcomes in patients hospitalized with heart failure in Japan. Circ J 2010; 74: 2605-2611.
8. Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers: An integrated viewpoint. Circ J 2010; 74: 1274-1282.
9. Glatz JF, Paulussen RJ, Veerkamp JH. Fatty acid binding proteins from heart. Chem Phys Lipids 1985; 38: 115-129.
10. Schaap FG, van der Vusse GJ, Glatz JF. Fatty acid-binding proteins in the heart. Mol Cell Biochem 1998; 180: 43-51.
11. Panteghini M. Standardization activities of markers of cardiac damage: The need of a comprehensive approach. Eur Heart J 1998; 19(Suppl N): N8-N11.
12. Setsuta K, Seino Y, Ogawa T, Arao M, Miyatake Y, Takano T. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure. Am J Med 2002; 113: 717-722.
13. Arimoto T, Takeishi Y, Shiga R, Fukui A, Tachibana H, Nozaki N, et al. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 2005; 11: 56-60.
14. Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, et al. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail 2007; 13: 120-127.
15. The Criteria Committee of the New York Heart Association. Diseases of the heart and blood vessels: Nomenclature and criteria for diagnosis, 6th edn. Boston: Little, Brown and Co, 1964.
16. Ross RD. Grading the graders of congestive heart failure in children J Pediatr 2001; 138: 618-620.
17. Ross RD, Daniels SR, Schwartz DC, Hannon DW, Shukla R, Kaplan S. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 1987; 59: 911-914.
18. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119.
19. Davies CH, Harding SE, Poole-Wilson PA. Cellular mechanisms of contractile dysfunction in human heart failure. Eur Heart J 1996;17: 189-198.
20. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996; 335: 1182-1189.
21. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, et al. Apoptosis in the failing human heart. N Engl J Med 1997; 336: 1131-1141.
22. Kostin S, Pool L, Elsasser A, Hein S, Drexler HC, Arnon E, et al. Myocytes die by multiple mechanisms in failing human hearts. Circ Res 2003; 18: 710-714.
23. Oktay B, Akbal E, Firat H, Ardic S, Akdemir R, Kizilgun M. Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome. Sleep Breath 2008; 12: 223-228.
24. Niizeki T, Takeishi Y, Takabatake N, Shibata Y, Konta T, Kato T, et al. Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: Effects of age, gender, and physiologic characteristics. Circ J 2007; 71: 1452-1457.
25. Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M, et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006; 47: 582-586.
26. Ritchie RH, Rosenkranz AC, Kaye DM. B-type natriuretic peptide: Endogenous regulator of myocardial structure, biomarker and therapeutic target. Curr Mol Med 2009; 9: 814-825.
27. Boerrigter G, Costello-Boerrigter LC, Burnett JC J. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin 2009; 5: 501-514.
28. Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: A new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138: 644-648.